Reestablishment of Active Immunity against HBV Graft Reinfection after Liver Transplantation for HBV-Related End Stage Liver Disease

Figure 3

There were no significant differences among patients with LF, HCC, LC, and HCC combined with LC in baseline anti-HBs titer, titer at successful establishment of immunity, the highest titer after vaccination, the highest titer after booster vaccination, titer when HBIG was withdrawn, and titer at the ending of followup. The lowest titer of the HCC group before booster vaccination was higher than that of the other groups (94.81 ± 3.84 IU/L versus 87.40 ± 57.29 IU/L, 277.90 ± 187.38 IU/L, 131.74 ± 59.90 IU/L, , and , vacc.: vaccination).